Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Other Non Operating Income (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Other Non Operating Income data on record, last reported at $3.0 million in Q3 2025.

  • For Q3 2025, Other Non Operating Income fell 31.11% year-over-year to $3.0 million; the TTM value through Sep 2025 reached $12.4 million, down 8.9%, while the annual FY2024 figure was $14.0 million, 9.28% down from the prior year.
  • Other Non Operating Income reached $3.0 million in Q3 2025 per GOSS's latest filing, up from $2.7 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $6.5 million in Q2 2023 and bottomed at -$332000.0 in Q3 2022.
  • Average Other Non Operating Income over 4 years is $2.6 million, with a median of $2.7 million recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: soared 1130.12% in 2023, then tumbled 57.98% in 2024.
  • A 4-year view of Other Non Operating Income shows it stood at $1.5 million in 2022, then skyrocketed by 161.54% to $3.8 million in 2023, then rose by 9.53% to $4.2 million in 2024, then decreased by 29.18% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $3.0 million in Q3 2025, $2.7 million in Q2 2025, and $2.6 million in Q1 2025.